# First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-crizotinib-versus-chemotherapy-in-i-alk-i-positive-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Benjamin Solomon,Tony Mok,Dong‐Wan Kim,Yi‐Long Wu,Kazuhiko Nakagawa,Tarek Mekhail,Enriqueta Felip,Federico Cappuzzo,Jolanda Paolini,Tiziana Usari,Shrividya Iyer,Arlene Reisman,Keith D. Wilner,Jennifer Tursi,Fiona Blackhall |
| Citations | 3,224 |
| DOI | 10.1056/nejmoa1408440 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1408440?articleTools=true |
| OpenAlex ID | https://openalex.org/W2099530756 |
| PMID | 25470694 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Benjamin Solomon](https://scholariq.org/researchers/benjamin-solomon/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.